External Quality Assessment of Bacterial Identification and Antimicrobial Susceptibility Testing in African National Public Health Laboratories, 2011–2016

Abstract

Background: In 2002, the World Health Organization (WHO) launched a regional microbiology external quality assessment (EQA) programme for national public health laboratories in the African region, initially targeting priority epidemic-prone bacterial diseases, and later including other common bacterial pathogens. Objectives: The aim of this study was to analyse the efficacy of an EQA programme as a laboratory quality system evaluation tool. Methods: We analysed the proficiency of laboratories' performance of bacterial identification and antimicrobial susceptibility testing (AST) for the period 2011-2016. The National Institute for Communicable Diseases of South Africa provided technical coordination following an agreement with WHO, and supplied EQA samples of selected bacterial organisms for microscopy (Gram stain), identification, and antimicrobial susceptibility testing (AST). National public health laboratories, as well as laboratories involved in the Invasive Bacterial Diseases Surveillance Network, were enrolled by the WHO Regional Office for Africa to participate in the EQA programme. We analysed participants' results of 41 surveys, which included the following organisms sent as challenges: Streptococcus pneumonia, Haemophilus influenzae, Neisseria meningitidis, Salmonella Typhi, Salmonella Enteritidis, Shigella flexneri, Staphylococcus aureus, Streptococcus agalactiae, Streptococcus anginosus, Enterococcus faecium, Serratia marcescens, Acinetobacter baumannii, and Enterobacter cloacae. Results: Eighty-one laboratories from 45 countries participated. Overall, 76% of participants obtained acceptable scores for identification, but a substantial proportion of AST scores were not in the acceptable range. Of 663 assessed AST responses, only 42% had acceptable scores. Conclusion: In the African Region, implementation of diagnostic stewardship in clinical bacteriology is generally suboptimal. This report illustrates that AST is poorly done compared to microscopy and identification. It is critically important to make the case for implementation of quality assurance in AST, as it is the cornerstone of antimicrobial resistance surveillance reporting and implementation of the Global Antimicrobial Resistance Surveillance System.

Laboratory-based surveillance of antimicrobial resistance in regions of Kenya: An assessment of capacities, practices, and barriers by means of multi-facility survey

“…Although this suggests that implementation of EQA programmes in Africa has improved over time, a vast majority of peripheral laboratories still lack EQA provision ( 34 ). In Kenya for instance, the WHO program serves two national facilities ( 35 ), a pattern that is likely to be similar throughout sub-Saharan African countries. There is therefore a need for the establishment of effective EQA schemes for bacterial identification and antimicrobial susceptibility testing in developing countries in order to ensure accuracy of laboratory investigations.…”

The need to improve antimicrobial susceptibility testing capacity in Ugandan health facilities: insights from a surveillance primer

“…Unreliable ASP also affects surveillance efforts. Constant training of lab staff and participation in external competence assessments has been shown to improve staff skills to group bacteria well [ 32 – 35 ]. The use of semi-automated or automated grouping systems has been shown to improve the grouping [ 36 – 38 ].…”

COVID-19 pandemic and antimicrobial resistance: Another call to strengthen laboratory diagnostic capacity in Africa

“…17 An external quality assessment report indicated poor performance of AST in several African countries. 18 Quality assurance in AST is key for reporting and implementation of the Global Antimicrobial Resistance Surveillance System 19 ; laboratories in Africa have to be supported with the needed investments for better performance.…”